JANE ARCHER: Open Payments
NPI 1619237476 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,580 in 26 payments from 5 companies in 2025. Trend: 2023 $2,875 · 2024 $106 · 2025 $2,580
Food & beverage: $1,432Travel & lodging: $1,149
| Company | Payments | Amount |
|---|---|---|
| MERZ NORTH AMERICA, INC. | 20 | $2,359 |
| REVANCE THERAPEUTICS, INC. | 2 | $159 |
| Currax Pharmaceuticals LLC | 2 | $27 |
| Lilly USA, LLC | 1 | $20 |
| Novo Nordisk Inc | 1 | $16 |
Products named: DAXXIFY, Xeomin, CONTRAVE, MOUNJARO, Wegovy.
Industry payments across IN — which companies pay providers there.
